1
项与 CD7 CAR T cells (iCell Gene Therapeutics) 相关的临床试验Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances
This is a phase I, interventional, single arm, open label, treatment study to evaluate the safety and tolerability of non-gene edited anti-CD7 CAR (also called anti-CD7 CAR) T cells in patients with relapsed and/or refractory T cell lymphoma or leukemia
100 项与 CD7 CAR T cells (iCell Gene Therapeutics) 相关的临床结果
100 项与 CD7 CAR T cells (iCell Gene Therapeutics) 相关的转化医学
100 项与 CD7 CAR T cells (iCell Gene Therapeutics) 相关的专利(医药)
100 项与 CD7 CAR T cells (iCell Gene Therapeutics) 相关的药物交易